PG vs RTX: Which Is the Better Buy?

Side-by-side comparison of The Procter & Gamble Company and RTX Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
The Procter & Gamble Company Β· Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction Grade B+ High Quality
VS
RTX Corporation Β· Industrials
$193.54
+33.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
RTX has more upside to fair value (+33.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric PG RTX
Current Price $147.04 $193.54
Fair Value Estimate $168.19 $257.36
Upside to Fair Value +14.4% +33.0%
Market Cap $349.5B $260.9B
Forward P/E β€” β€”
EV / EBITDA 17.6x 18.1x
Price / Sales 4.0x 2.8x
Price / FCF 22.4x 21.7x
Revenue Growth YoY +1.5% +14.5%
Gross Margin 50.2% 20.3%
Operating Margin 22.7% 11.2%
Return on Equity 29.8% 11.8%
Dividend Yield 2.92% 1.46%
FCF Yield 4.47% 4.6%
Analyst Consensus Buy Buy
Investment Thesis
PG β€” The Procter & Gamble Company
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
RTX β€” RTX Corporation
RTX Corporation is a $260.85 billion aerospace and defense conglomerate operating three segments β€” Collins Aerospace, Pratt & Whitney, and Raytheon β€” serving commercial aviation, military, and government customers worldwide with 180,000 employees. The business quality is high: it holds intangible-asset and switching-cost advantages rooted in long-cycle engine programs, proprietary defense electro…
Accumulation Zones
Metric PG RTX
Zone Low $126.14 $193.02
Zone High $142.96 $218.76
In Buy Zone? No Yes
← PG Research    RTX Research β†’    All Research